GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Shiller PE Ratio

JCR Pharmaceuticals Co (TSE:4552) Shiller PE Ratio : 16.52 (As of May. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Shiller PE Ratio?

As of today (2024-05-21), JCR Pharmaceuticals Co's current share price is 円636.00. JCR Pharmaceuticals Co's E10 for the quarter that ended in Dec. 2023 was 円38.51. JCR Pharmaceuticals Co's Shiller PE Ratio for today is 16.52.

The historical rank and industry rank for JCR Pharmaceuticals Co's Shiller PE Ratio or its related term are showing as below:

TSE:4552' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.15   Med: 110.89   Max: 222.36
Current: 16.15

During the past years, JCR Pharmaceuticals Co's highest Shiller PE Ratio was 222.36. The lowest was 16.15. And the median was 110.89.

TSE:4552's Shiller PE Ratio is ranked better than
73.03% of 534 companies
in the Drug Manufacturers industry
Industry Median: 24.98 vs TSE:4552: 16.15

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

JCR Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Dec. 2023 was 円-0.750. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円38.51 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


JCR Pharmaceuticals Co Shiller PE Ratio Historical Data

The historical data trend for JCR Pharmaceuticals Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co Shiller PE Ratio Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 158.12 182.51 72.47 40.87 -

JCR Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.87 35.34 38.36 30.44 -

Competitive Comparison of JCR Pharmaceuticals Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Shiller PE Ratio falls into.



JCR Pharmaceuticals Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

JCR Pharmaceuticals Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=636.00/38.51
=16.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, JCR Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.75/106.8000*106.8000
=-0.750

Current CPI (Dec. 2023) = 106.8000.

JCR Pharmaceuticals Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 1.133 95.700 1.264
201406 2.103 98.000 2.292
201409 1.515 98.500 1.643
201412 3.603 97.900 3.931
201503 5.943 97.900 6.483
201506 3.503 98.400 3.802
201509 4.763 98.500 5.164
201512 3.720 98.100 4.050
201603 1.968 97.900 2.147
201606 2.190 98.100 2.384
201609 5.840 98.000 6.364
201612 3.105 98.400 3.370
201703 3.518 98.100 3.830
201706 3.903 98.500 4.232
201709 10.970 98.800 11.858
201712 4.898 99.400 5.263
201803 4.758 99.200 5.123
201806 2.285 99.200 2.460
201809 8.840 99.900 9.451
201812 3.950 99.700 4.231
201903 14.915 99.700 15.977
201906 2.983 99.800 3.192
201909 4.458 100.100 4.756
201912 7.120 100.500 7.566
202003 7.030 100.300 7.486
202006 6.180 99.900 6.607
202009 3.710 99.900 3.966
202012 16.410 99.300 17.649
202103 29.230 99.900 31.249
202106 12.340 99.500 13.245
202109 62.020 100.100 66.171
202112 29.670 100.100 31.656
202203 12.770 101.100 13.490
202206 11.020 101.800 11.561
202209 -3.290 103.100 -3.408
202212 20.870 104.100 21.411
202303 1.610 104.400 1.647
202306 12.850 105.200 13.045
202309 29.050 106.200 29.214
202312 -0.750 106.800 -0.750

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


JCR Pharmaceuticals Co  (TSE:4552) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


JCR Pharmaceuticals Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


JCR Pharmaceuticals Co (TSE:4552) Business Description

Traded in Other Exchanges
Address
3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines